Major depressive disorder (MDD) is a psychiatric condition characterized by persistent feelings of sadness, a loss of ...

Such brain imaging helped researchers better target accelerated transcranial magnetic stimulation (aTMS), producing a ...

A single 100-microgram dose of DT120 produced rapid and lasting antidepressant effects that were significantly better than ...

A single dose of the LSD-based therapy DT120 produced rapid antidepressant effects that remained significant through 12 weeks in a pivotal phase 3 trial of major depressive disorder.

People taking Definium Therapeutics' DT120 showed long-lasting reductions in their depression symptoms compared to a placebo, ...

Definium said it will host a webcast on Tuesday morning to discuss results from Emerge, a Phase 3 study evaluating DT120 ODT ...

A study linking accelerated immune-cell aging to emotional, but not physical, depressive symptoms strengthens evidence that ...

A proof-of-concept study suggests the 5-HT4 receptor agonist prucalopride, which is approved for chronic constipation, ...

Mental health professionals use the DSM to standardize the diagnosis and treatment processes for mental health conditions, including types of depression. The Diagnostic and Statistical Manual of ...

Depressive disorders, including major depressive disorder, impair functioning and affect 280 million people globally. Traditional treatments are not fully effective. Transcranial direct current ...

Worldwide, the incidence of major depressive disorder (MDD) is increasing annually, resulting in greater economic and social burdens. Moreover, the pathological mechanisms of MDD and the mechanisms ...

Researchers found that 8.3% of US adults had at least one major depressive episode. In adolescents, the rate was 20.1%, with 29.2% of female adolescents reporting a major depressive episode. Major ...